PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 161 filers reported holding PROGENICS PHARMACEUTICALS IN in Q1 2017. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $8,019,000 | -32.5% | 1,278,929 | -13.4% | 0.00% | 0.0% |
Q2 2018 | $11,877,000 | +8.1% | 1,477,229 | +0.3% | 0.00% | 0.0% |
Q1 2018 | $10,983,000 | -0.5% | 1,472,229 | -20.6% | 0.00% | 0.0% |
Q4 2017 | $11,038,000 | -38.7% | 1,855,156 | -24.2% | 0.00% | -50.0% |
Q3 2017 | $18,011,000 | -0.7% | 2,447,156 | -8.4% | 0.00% | 0.0% |
Q2 2017 | $18,131,000 | -35.7% | 2,670,196 | -10.6% | 0.00% | -50.0% |
Q1 2017 | $28,208,000 | -8.8% | 2,988,126 | -16.5% | 0.00% | 0.0% |
Q4 2016 | $30,933,000 | +41.2% | 3,580,156 | +3.4% | 0.00% | +33.3% |
Q3 2016 | $21,909,000 | +55.3% | 3,461,156 | +3.5% | 0.00% | +50.0% |
Q2 2016 | $14,108,000 | -24.3% | 3,343,223 | -21.8% | 0.00% | -33.3% |
Q1 2016 | $18,645,000 | -42.0% | 4,276,279 | -18.4% | 0.00% | -25.0% |
Q4 2015 | $32,135,000 | +5.4% | 5,242,279 | -1.7% | 0.00% | 0.0% |
Q3 2015 | $30,500,000 | -22.0% | 5,332,151 | +1.7% | 0.00% | -20.0% |
Q2 2015 | $39,107,000 | +19.9% | 5,242,279 | -3.9% | 0.01% | +25.0% |
Q1 2015 | $32,618,000 | -17.7% | 5,454,546 | +4.0% | 0.00% | -20.0% |
Q4 2014 | $39,632,000 | +51.4% | 5,242,279 | +3.9% | 0.01% | +25.0% |
Q3 2014 | $26,176,000 | +49.0% | 5,043,542 | +23.7% | 0.00% | +100.0% |
Q2 2014 | $17,568,000 | -2.5% | 4,076,046 | -7.5% | 0.00% | -33.3% |
Q1 2014 | $18,020,000 | -45.2% | 4,405,946 | -28.6% | 0.00% | -40.0% |
Q4 2013 | $32,892,000 | -25.3% | 6,171,046 | -29.5% | 0.01% | -28.6% |
Q3 2013 | $44,054,000 | +16.2% | 8,758,346 | +3.0% | 0.01% | +16.7% |
Q2 2013 | $37,924,000 | – | 8,503,246 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 1,583,925 | $8,007,000 | 1.48% |
Phocas Financial Corp. | 1,022,708 | $5,169,000 | 0.55% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,776,490 | $8,980,000 | 0.32% |
FARALLON CAPITAL MANAGEMENT LLC | 7,350,000 | $37,154,000 | 0.28% |
NEXPOINT ASSET MANAGEMENT, L.P. | 716,880 | $3,624,000 | 0.23% |
J. Goldman & Co LP | 499,698 | $2,526,000 | 0.19% |
PINNACLE ASSOCIATES LTD | 1,257,098 | $6,355,000 | 0.15% |
CARILLON TOWER ADVISERS, INC. | 3,948,024 | $19,957,000 | 0.14% |
EAGLE ASSET MANAGEMENT INC | 4,504,094 | $22,768,000 | 0.12% |
Worth Venture Partners, LLC | 32,956 | $167,000 | 0.10% |